Rate My Professor José-Alain Sahel

Dr. Sahel earned his medical degree from Paris University Medical School (1976–1980) and completed ophthalmology residency training at the Rothschild Ophthalmology Foundation and neurosurgery residency at Louis Pasteur University Hospital in Strasbourg, followed by a clinical fellowship there. He pursued additional research training as a research fellow at Massachusetts Eye and Ear Infirmary, Harvard Medical School, and as a visiting scholar at Harvard University. Prior to joining the University of Pittsburgh, he founded and directed the Institut de la Vision in Paris (2008–2020) and held leadership roles at Quinze-Vingts National Ophthalmology Hospital. His research centers on the cellular and molecular mechanisms of retinal degeneration and the development of therapies for inherited retinal dystrophies and age-related macular degeneration, encompassing neuroprotection, stem cells, gene therapy, optogenetics, pharmacology, and visual prostheses. He has authored more than 700 peer-reviewed articles and co-authored more than 90 patents, co-founded multiple companies advancing retinal therapies, and serves on editorial boards including those of Science Translational Medicine and Progress in Retinal and Eye Research. Dr. Sahel has received numerous honors, including the 2024 Wolf Prize in Medicine, the 2026 ARVO Proctor Medal, election to the French Academy of Sciences, and appointment to the French Presidential Council for Science in 2023. He maintains additional appointments as Emeritus Professor at Sorbonne Université, Adjunct Professor at Carnegie Mellon University and Hebrew University of Jerusalem, and Honorary Professor at University College London.